Cantor Fitzgerald initiates Sagimet Biosciences with Overweight rating
Cantor Fitzgerald initiated Sagimet Biosciences with an Overweight rating and announced a $10.71/share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.